Whereas, corporate lobbying exposes our company to risks that could affect the company’s stated goals, objectives, and ultimately shareholder value. Whereas, we rely on information provided by our company to evaluate goals and objectives, and we, therefore, have a strong interest in full disclosure of our company’s lobbying to assess whether it’s lobbying is consistent with its expressed goals and in the best interests of shareholders and long-term value. Resolved, the shareholders of Endo Pharmaceuticals Holdings Inc. (“Endo”) request the Board authorize the preparation of a report, updated annually, disclosing: Company policy and procedures governing lobbying, both direct and indirect, …